Back to Search Start Over

Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation.

Authors :
Serban, Teodor
Hennings, Elisa
Strebel, Ivo
Knecht, Sven
du Fay de Lavallaz, Jeanne
Krisai, Philipp
Arnet, Rebecca
Völlmin, Gian
Osswald, Stefan
Sticherling, Christian
Kühne, Michael
Badertscher, Patrick
Source :
Heart Rhythm; Sep2024, Vol. 21 Issue 9, p1581-1588, 8p
Publication Year :
2024

Abstract

Atrial fibrillation (AF) and heart failure frequently coexist. Prediction of left ventricular ejection fraction (LVEF) recovery after catheter ablation (CA) for AF remains difficult. The purpose of this study was to evaluate the value of biomarkers, alone and in combination with the Antwerp score, to predict LVEF recovery after CA for AF. Patients undergoing CA for AF with depressed LVEF (<50%) were included. Plasma levels of 13 biomarkers were measured immediately before CA. Patients were categorized into "responders" and "nonresponders" in a similar fashion to the Antwerp score performance derivation and validation cohorts. The predictive power of the biomarkers alone and combined in outcome prediction was evaluated. A total of 208 patients with depressed LVEF were included (median age 63 years; 39–19% female; median indexed left atrial volume 42 (33–52) mL/m<superscript>2</superscript>; median LVEF 43 (38–46)%). At a median follow-up time of 30 (20–34) months, 161 (77%) were responders and 47 (23%) were nonresponders. Of 13 biomarkers, –4—angiopoietin 2 (ANG2), growth differentiation factor 15 (GDF15), fibroblast growth factor 23, and myosin binding protein C3—were significantly different between responders and nonresponders (P ≤.001) and their combination could predict the end point with an area under the curve of 0.72 (95% confidence interval [CI] 0.64–0.81) overall, 0.69 (95% CI 0.59–0.78) in heart failure with mildly reduced ejection fraction, and 0.88 (95% CI 0.77–0.98) in heart failure with reduced ejection fraction. Only ANG2 and GDF15 remained significantly associated with LVEF recovery after adjustment for age, sex, and Antwerp score and significantly improved the accuracy of the Antwerp score predictions (P <.001). The area under the curve of the Antwerp score in the outcome prediction improved from 0.75 (95% CI 0.67–0.83) to 0.78 (95% CI 0.70–0.86). A biomarker panel (ANG2 and GDF15) significantly improved the accuracy of the Antwerp score. [Display omitted] [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15475271
Volume :
21
Issue :
9
Database :
Supplemental Index
Journal :
Heart Rhythm
Publication Type :
Academic Journal
Accession number :
178977044
Full Text :
https://doi.org/10.1016/j.hrthm.2024.04.044